Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-EN
Language French English
Date Updated 2019-05-28 2019-04-20
Drug Identification Number 02182971 02182971
Brand name METHOTREXATE INJECTION USP METHOTREXATE INJECTION USP
Common or Proper name Methotrexate Methotrexate
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients METHOTREXATE METHOTREXATE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100mL Vial 100mL Vial
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-04-19 2019-04-19
Actual start date 2019-04-24
Estimated end date 2019-05-31 2019-05-10
Actual end date 2019-05-16
Shortage status Resolved Actual shortage
Company comments Other presentation are available Other presentation are available
Health Canada comments